|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0150 CAD | +50.00% |
|
-.--% | -25.00% |
| 07-17 | Waverley Pharma Inc. Announces CFO Changes, Effective July 24, 2026 | CI |
| 05-22 | Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 581K | - | - | - | - | - |
| 68.12B | |||||
| 55.18B | |||||
| 28.63B | - | ||||
| 23.53B | - | ||||
| 23.99B |
- Stock Market
- Stocks
- WAVE Stock
- Charts Waverley Pharma Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
